Perrigo Price to Sales Ratio 2010-2024 | PRGO
Historical PS ratio values for Perrigo (PRGO) over the last 10 years. The current P/S ratio for Perrigo as of December 24, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Perrigo P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-12-24 | 25.64 | 0.80 | |
| 2024-09-30 | 25.98 | $32.10 | 0.81 |
| 2024-06-30 | 25.20 | $32.40 | 0.78 |
| 2024-03-31 | 31.58 | $33.36 | 0.95 |
| 2023-12-31 | 31.28 | $34.25 | 0.91 |
| 2023-09-30 | 30.78 | $34.29 | 0.90 |
| 2023-06-30 | 32.46 | $34.26 | 0.95 |
| 2023-03-31 | 34.00 | $33.86 | 1.00 |
| 2022-12-31 | 32.07 | $33.11 | 0.97 |
| 2022-09-30 | 33.28 | $32.80 | 1.01 |
| 2022-06-30 | 37.60 | $32.42 | 1.16 |
| 2022-03-31 | 35.38 | $31.43 | 1.13 |
| 2021-12-31 | 35.56 | $31.08 | 1.14 |
| 2021-09-30 | 42.97 | $30.10 | 1.43 |
| 2021-06-30 | 41.39 | $29.21 | 1.42 |
| 2020-12-31 | 39.94 | $29.76 | 1.34 |
| 2020-09-30 | 40.81 | $24.68 | 1.65 |
| 2020-06-30 | 48.92 | $24.90 | 1.96 |
| 2020-03-31 | 42.39 | $26.70 | 1.59 |
| 2019-12-31 | 45.34 | $27.23 | 1.66 |
| 2021-03-31 | 36.35 | $33.25 | 1.09 |
| 2019-09-30 | 48.85 | $34.39 | 1.42 |
| 2019-06-30 | 41.44 | $33.93 | 1.22 |
| 2019-03-31 | 41.70 | $34.07 | 1.22 |
| 2018-12-31 | 33.42 | $34.05 | 0.98 |
| 2018-09-30 | 61.07 | $34.40 | 1.77 |
| 2018-06-30 | 62.73 | $34.85 | 1.80 |
| 2018-03-31 | 71.52 | $34.93 | 2.05 |
| 2017-12-31 | 74.62 | $34.64 | 2.15 |
| 2017-09-30 | 72.34 | $34.93 | 2.07 |
| 2017-06-30 | 64.40 | $35.05 | 1.84 |
| 2017-03-31 | 56.49 | $35.77 | 1.58 |
| 2016-12-31 | 70.67 | $36.86 | 1.92 |
| 2016-09-30 | 78.27 | $20.57 | 3.80 |
| 2016-06-30 | 76.73 | $20.43 | 3.76 |
| 2016-03-31 | 108.10 | $17.94 | 6.03 |
| 2015-12-31 | 122.13 | $16.37 | 7.46 |
| 2015-09-30 | 132.63 | $30.45 | 4.36 |
| 2015-03-31 | 139.43 | $21.78 | 6.40 |
| 2014-12-31 | 140.67 | $22.39 | 6.28 |
| 2014-09-30 | 126.31 | $24.48 | 5.16 |
| 2014-06-30 | 122.49 | $27.25 | 4.49 |
| 2014-03-31 | 129.87 | $27.25 | 4.77 |
| 2013-12-31 | 128.78 | $29.51 | 4.36 |
| 2013-09-30 | 103.48 | $28.93 | 3.58 |
| 2013-06-30 | 101.41 | $27.24 | 3.72 |
| 2013-03-31 | 99.44 | $27.24 | 3.65 |
| 2012-12-31 | 87.05 | $25.77 | 3.38 |
| 2012-09-30 | 97.12 | $25.34 | 3.83 |
| 2012-06-30 | 98.52 | $24.90 | 3.96 |
| 2012-03-31 | 86.24 | $24.90 | 3.46 |
| 2011-12-31 | 81.16 | $24.02 | 3.38 |
| 2011-09-30 | 80.93 | $22.80 | 3.55 |
| 2011-06-30 | 73.18 | $21.95 | 3.33 |
| 2011-03-31 | 66.17 | $21.95 | 3.01 |
| 2010-12-31 | 52.64 | $20.37 | 2.58 |
| 2010-09-30 | 53.32 | $22.36 | 2.39 |
| 2010-06-30 | 49.00 | $21.74 | 2.25 |
| 2010-03-31 | 48.65 | $27.40 | 1.78 |
| 2015-06-30 | 155.77 | $21.59 | 7.21 |
| 2009-12-31 | 32.96 | $17.35 | 1.90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.513B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.127B | 25.27 |
| Stryker (SYK) | United States | $138.991B | 31.32 |
| Boston Scientific (BSX) | United States | $131.097B | 37.69 |
| EssilorLuxottica (ESLOY) | France | $109.895B | 0.00 |
| Medtronic (MDT) | Ireland | $103.904B | 15.43 |
| Haleon (HLN) | United Kingdom | $43.864B | 28.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.859B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.052B | 18.70 |
| ResMed (RMD) | United States | $34.830B | 28.62 |
| Terumo (TRUMY) | Japan | $28.875B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.602B | 18.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.325B | 13.58 |
| Insulet (PODD) | United States | $18.698B | 74.46 |
| Baxter (BAX) | United States | $15.062B | 9.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.781B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.800B | 39.43 |
| Bio-Rad Laboratories (BIO) | United States | $9.168B | 31.16 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.208B | 14.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.889B | 19.34 |
| ICU Medical (ICUI) | United States | $3.840B | 36.56 |
| Haemonetics (HAE) | United States | $3.789B | 18.49 |
| Envista Holdings (NVST) | United States | $3.218B | 23.97 |
| QuidelOrtho (QDEL) | United States | $3.016B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.609B | 30.10 |
| LeMaitre Vascular (LMAT) | United States | $2.071B | 50.34 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 29.37 |
| AtriCure (ATRC) | United States | $1.498B | 0.00 |
| InMode (INMD) | Israel | $1.434B | 8.63 |
| AdaptHealth (AHCO) | United States | $1.383B | 9.88 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.271B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.968B | 0.00 |
| Owens & Minor (OMI) | United States | $0.965B | 7.54 |
| CeriBell (CBLL) | United States | $0.964B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.879B | 15.49 |
| Evolus (EOLS) | United States | $0.690B | 0.00 |
| Omeros (OMER) | United States | $0.597B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.594B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.584B | 25.75 |
| Surmodics (SRDX) | United States | $0.568B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.452B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.439B | 0.00 |
| Quanterix (QTRX) | United States | $0.403B | 0.00 |
| ZimVie (ZIMV) | United States | $0.375B | 31.63 |
| Biote (BTMD) | United States | $0.331B | 7.26 |
| Valneva SE (VALN) | France | $0.324B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.311B | 29.56 |
| Canopy Growth (CGC) | Canada | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Cerus (CERS) | United States | $0.293B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
| Zynex (ZYXI) | United States | $0.263B | 55.00 |
| High Tide (HITI) | Canada | $0.242B | 100.33 |
| Aurora Cannabis (ACB) | Canada | $0.234B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 14.29 |
| Sanuwave Health (SNWV) | United States | $0.201B | 2.82 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.190B | 0.00 |
| Brainsway (BWAY) | Israel | $0.174B | 92.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.17 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.81 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Exagen (XGN) | United States | $0.091B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.067B | 34.67 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.74 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |